Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | (Q3)Jul 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -10.13%2.77B | -8.21%2.64B | 3.63%11.89B | -3.07%3.13B | 5.86%2.8B | 1.95%3.09B | 11.71%2.87B | -15.98%11.47B | 9.88%3.23B | -23.74%2.64B |
Cost of revenue | 1.13%2.54B | -0.95%2.25B | 4.16%10.02B | -1.85%2.86B | 9.33%2.37B | 1.13%2.51B | 10.94%2.27B | -20.48%9.62B | 11.43%2.91B | -28.52%2.17B |
Gross profit | -59.66%230.4M | -35.50%389.59M | 0.85%1.87B | -14.39%268.57M | -10.08%424.36M | 5.72%571.21M | 14.72%603.98M | 18.97%1.85B | -2.73%313.71M | 10.18%471.94M |
Operating expense | -6.33%304.77M | -5.26%309.32M | 10.22%1.31B | 5.73%345.88M | 11.95%316.52M | 16.07%325.38M | 8.03%326.5M | 3.69%1.19B | 8.51%327.14M | -4.66%282.74M |
Operating profit | -130.25%-74.37M | -71.07%80.27M | -16.08%553.83M | -475.65%-77.31M | -43.00%107.84M | -5.44%245.83M | 23.75%277.47M | 62.12%659.94M | -163.89%-13.43M | 43.60%189.19M |
Net non-operating interest income (expenses) | -278.06%-1.95M | -170.74%-1.02M | -139.32%-2.2M | -187.79%-754K | -112.31%-552K | -166.84%-515K | -85.22%-376K | -51.74%-918K | -49.71%-262K | -48.57%-260K |
Non-operating interest expense | 278.06%1.95M | 170.74%1.02M | 139.32%2.2M | 187.79%754K | 112.31%552K | 166.84%515K | 85.22%376K | 51.74%918K | 49.71%262K | 48.57%260K |
Net investment income | 0 | 23.10%24.58M | 16.84%46.34M | 0 | 12.67%26.37M | 0 | 22.84%19.97M | 40.14%39.66M | 0 | 45.81%23.41M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | -43.29%12.28M | 3.26%16.69M | 371.10%84.98M | 2,708.14%18.91M | 244.59%28.25M | 387.93%21.66M | 553.65%16.16M | -214.32%-31.35M | 96.22%-725K | -234.77%-19.54M |
Special income (charges) | -18.70%13.31M | -14.67%10.87M | -9.43%54.14M | -7.55%12.76M | -20.64%12.27M | -4.65%16.37M | -4.53%12.74M | 434.38%59.78M | 123.34%13.8M | 32.33%15.46M |
Less:Other special charges | 18.70%-13.31M | 14.67%-10.87M | 9.43%-54.14M | 7.55%-12.76M | 20.64%-12.27M | 4.65%-16.37M | 4.53%-12.74M | -11.95%-59.78M | -13.81%-13.8M | -32.33%-15.46M |
Other non-operating income (expenses) | -63.91%7.17M | -59.03%9.87M | -28.71%58.33M | -36.34%10.49M | -79.68%3.88M | -22.43%19.87M | 16.76%24.09M | -10.34%81.83M | -20.80%16.48M | 0.23%19.1M |
Income before tax | -114.36%-43.55M | -59.65%141.25M | -1.67%795.42M | -326.25%-35.9M | -21.69%178.05M | 2.77%303.22M | 29.32%350.05M | 51.04%808.95M | 143.28%15.87M | 17.89%227.37M |
Income tax | -83.09%17.29M | -53.43%54.66M | 5.80%314.12M | 104.12%41.37M | -32.99%53.13M | -8.33%102.25M | 36.78%117.38M | 27.90%296.9M | -52.51%20.27M | 26.83%79.28M |
Net income | -130.28%-60.85M | -62.78%86.59M | -6.01%481.29M | -1,657.31%-77.27M | -15.64%124.93M | 9.52%200.97M | 25.86%232.67M | 68.75%512.05M | 94.46%-4.4M | 13.61%148.09M |
Net income continuous operations | -130.28%-60.85M | -62.78%86.59M | -6.01%481.3M | -1,657.31%-77.27M | -15.64%124.93M | 9.52%200.97M | 25.86%232.67M | 68.75%512.05M | 94.46%-4.4M | 13.61%148.09M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -130.28%-60.85M | -62.78%86.59M | -6.01%481.29M | -1,657.31%-77.27M | -15.64%124.93M | 9.52%200.97M | 25.86%232.67M | 68.75%512.05M | 94.46%-4.4M | 13.61%148.09M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -130.28%-60.85M | -62.78%86.59M | -6.01%481.29M | -1,657.31%-77.27M | -15.64%124.93M | 9.52%200.97M | 25.86%232.67M | 68.75%512.05M | 94.46%-4.4M | 13.61%148.09M |
Gross dividend payment | ||||||||||
Basic earnings per share | -130.27%-20.62 | -62.78%29.35 | -6.00%163.14 | -1,657.72%-26.19 | -15.62%42.35 | 9.54%68.12 | 25.85%78.86 | 68.76%173.55 | 94.46%-1.49 | 13.60%50.19 |
Diluted earnings per share | -130.28%-20.6247 | -62.78%29.35 | -6.00%163.14 | -1,657.36%-26.1908 | -15.63%42.3443 | 9.53%68.1171 | 25.85%78.86 | 68.76%173.55 | 94.46%-1.4903 | 13.62%50.19 |
Dividend per share | -50.00%10 | 0 | 12.50%45 | 25.00%25 | 0 | 0.00%20 | 0 | 0.00%40 | 0.00%20 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |